2.9100 -0.38 (-11.55%)
After hours: 7:59PM EST
|Bid||2.9000 x 21500|
|Ask||2.9100 x 42300|
|Day's Range||3.1100 - 3.4300|
|52 Week Range||3.1100 - 10.3200|
|Beta (3Y Monthly)||1.97|
|PE Ratio (TTM)||15.23|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Aurora Cannabis has announced plans to shore up its balance sheet that include halting construction plans at facilities in Alberta and Denmark.
Ask Benjamin Witte about Recess, and one of the first places he’ll send you is the company’s Instagram page.
Aurora Cannabis Inc. (ACB) delivered earnings and revenue surprises of 133.33% and -21.69%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?
TORONTO , Nov. 14, 2019 /CNW/ - Aurora Cannabis Inc. ("Aurora" or the "Company") (NYSE | TSX: ACB), the Canadian company defining the future of cannabis worldwide, announced today that it has provided notice to all holders (the "Debentureholders") of the Company's CAD$230 million 5% unsecured, convertible debentures due March 9, 2020 (the "Debentures") of an opportunity to voluntarily convert their Debentures at the Amended Early Conversion Ratio (as defined herein). All Debentureholders will be able to convert their Debentures at the Amended Early Conversion Ratio during the period commencing on November 18, 2019 and ending at 5:00 p.m. ( Toronto time) on November 20, 2019 (the "Early Conversion Period").
NYSE | TSX: ACB Reports Industry Leading Gross Profit of $53.7 Million and 58% Cannabis Gross Margin Delivers Best-in-Class Indoor Cash Cost to Produce of $0.85 per gram Announces Plan to Settle March ...
TORONTO — Some of the most active companies traded Thursday on the Toronto Stock Exchange:Toronto Stock Exchange (16,972.18, up 14.19 points.)Aurora Cannabis Inc. (TSX:ACB). Health care. Down 31 cents, or 6.61 per cent, to $4.38 on 8.2 million shares.Manulife Financial Corp. (TSX:MFC). Financials. Unchanged at $26.26 on 7 million shares.Canopy Growth Corp. (TSX:WEED). Health care. Down $3.49 or 14.27 per cent, to $20.96 on 5.5 million shares.The Green Organic Dutchman Holdings. (TSX:TGOD). Health care. Down nine cents, or 9.78 per cent, to 83 cents on 5.5 million shares.Encana Corp. (TSX:ECA). Energy. Down 11 cents, or 1.88 per cent, to $5.75 on 4.7 million shares.Enbridge Inc. (TSX:ENB). Energy. Down $1.37 or 2.67 per cent, to $50.00 on 4 million shares. Companies in the news:Cineplex Inc. (TSX:CGX). Up $1.22 or 5.3 per cent to $24.32. Cineplex Inc. shares rose after the company reported record high revenue for its third quarter and outperformed analyst expectations, helped by a strong film slate including "The Lion King" and "Spider-Man: Far From Home." Cineplex reported Thursday that its third-quarter profit rose to $13.4 million from $10.2 million a year earlier. Revenue grew 8.3 per cent to a record $418.4 million as theatre attendance increased 1.8 per cent due to what Cineplex called a stronger film slate compared with last year. In addition to The Lion King and Spider-Man, Cineplex attributed the strength to films such as "Fast & Furious Presents: Hobbs & Shaw," "It Chapter Two" and "Once Upon a Time in Hollywood."Freshii Inc. (TSX:FRII). Down one cent to $2.70. Freshii Inc. continued to see traffic to its health-food eateries fall during its most recent quarter, but the company believes upcoming initiatives including a loyalty program can win over consumers. Same-store sales, a key retail metric, fell 3.7 per cent for the quarter ended Sept. 29. CEO Matthew Corrin said the company's current program, which focuses on offering limited-time menu items, isn't driving new traffic. Freshii's digital marketing campaigns and other initiatives expected to roll out next year will look to lure new customers into its stores, he said.Canopy Growth Corp. — Canopy Growth Corp.'s share price hit a 2019 low Thursday after the Canadian cannabis producer posted a $374.6-million quarterly loss, missed analyst revenue estimates and warned that a key revenue target may not be achieved. The company announced that second-quarter net revenue totalled $76.6 million, which was down 15 per cent from the prior quarter and below an average estimate of $107 million compiled by financial markets data firm Refinitiv. Interim chief executive Mark Zekulin also told analysts during a conference call that his previous projection of $250 million in revenue for the company's fourth quarter, ending in March, "is increasingly unlikely."Chorus Aviation Inc. (TSX:CHR). Up five cents to $8.20. Chorus Aviation Inc. reported a profit of $24.2 million in its latest quarter as revenue increased 2.8 per cent compared with a year ago. The regional aircraft company says the profit amounted to 15 cents per share for the quarter ended Sept. 30, weighed down by a $7.1-million loss on foreign exchange. The result compared with a profit of $43.6 million or 31 cents per share a year ago when it benefited from an $11.3-million gain on foreign exchange. Operating revenue totalled nearly $351.5 million, up from $342 million.This report by The Canadian Press was first published Nov. 14, 2019. The Canadian Press
The following items require special investor focus in the upcoming quarterly earnings of Aurora Cannabis (TSX:ACB)(NYSE:ACB).
All Items of Business Approved EDMONTON , Nov. 11, 2019 /CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora" or the "Issuer") (NYSE │ TSX: ACB), the Canadian company defining ...
Solid prospects in the Canadian and international markets are expected to have driven Aurora Cannabis' (ACB) fiscal first-quarter performance.
While a sluggish freight scenario is likely to affect Radiant Logistics' (RLGT) Q1 results, its higher revenues at the U.S. segment are expected to have aided the top line.
RAMM Pharma Corp. (including its wholly owned subsidiaries, the “Company” or "RAMM") (CSE:RAMM), a leader in plant-derived cannabinoid pharmaceutical products, is pleased to announce that trading in its common shares on the Canadian Securities Exchange will commence today at 9:30 a.m. (EST) under the ticker symbol “RAMM”. RAMM is one of the leaders in the field of cannabinoid pharmacology and product formulation for cannabis-derived prescription drugs and registered products.
The latest U.S.-China trade war news that could see the world's two largest economies roll back tariffs. Q3 earnings results from the likes of Qualcomm and Square. And why Yeti is a Zacks Rank 1 (Strong Buy) stock...